Objective The objective of this study was to investigate the molecular mechanism of zinc ions in treating spinal cord injury and to provide a research basis for the clinical use of zinc ions in this regard.Methods To investigate the molecular mechanism of zinc ions in treating spinal cord injury,we divided mice into two groups: spinal cord injury group and post-spinal cord injury zinc ion treatment group.We used single-cell sequencing technology to sequence the transcriptome.We further divided the mice into five groups:control group,sham-operated group,spinal cord injury group,spinal cord injury zinc ion treatment group,and IL-17 pathway inhibition group.We employed PCR-Array,tissue immunofluorescence,western blot,and q RT-PCR to validate the experiments.Results1、Zinc ion therapy for spinal cord injury in mice showed better functional recovery,and sequencing results showed the activation of the IL-17 signaling pathway.2、The use of gene chip technology successfully validated the activation of the IL-17 signaling pathway by zinc ion therapy in animals.The effect of the activated IL-17 signaling pathway by zinc ion therapy was an increase in neutrophil aggregation and a decrease in the expression of inflammatory factors at the site of spinal cord injury.3、Inhibition of the IL-17 signaling pathway in the zinc ion therapy group weakened the phenomenon of functional recovery,increased neutrophil aggregation,and reduced expression of inflammatory factors caused by zinc ion therapy.4 、 Single-cell sequencing of neutrophils in the site of spinal cord injury suggested immunoheterogeneity of neutrophils in the zinc ion therapy groupConclusions1、Zinc ion therapy promotes non-classical activation of the IL-17 pathway after spinal cord injury.2 、 Zinc ion therapy promotes immunoheterogeneity of neutrophils after spinal cord injury.3、Zinc ion therapy can promote spinal cord injury recovery through the above-mentioned ways. |